Priority Date: 31.08.12 (US 201261695409P)

MONOCLONAL ANTIBODIES FOR ENHANCING OR INHIBITING INSULIN-LIKE GROWTH FACTOR 1 (IGF-1)

  • Application ID: EP13832446
  • Status: GRANT OF PATENT INTENDED

Applicant

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This EP application has the IPC class A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 129 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 31.08.2012 - Priority Date (US 201261695409P)
  • 06.03.2014 - Publication A1 (WO2014036385)
  • 08.07.2015 - Publication A1 (EP2890716)

IPC Classification